Skip to main content

Evaluation of cyclooxygenase 2 inhibitor use in patients admitted to a large teaching hospital

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract Background: 

The heavy usage of coxibs in Australia far outstrips the predicted usage that was based on the treatment of patients with risk factors for upper gastro­intestinal adverse events from conventional anti-­inflammatory agents. This raises questions regarding the appropriateness of prescribing.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: COX-2 inhibitors; evaluation; usage

Document Type: Original Article

Affiliations: 1: Department of Clinical Pharmacology and 2: Department of Pharmacy, Princess Alexandra Hospital, Brisbane, Queensland, Australia

Publication date: 2003-05-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more